211 related articles for article (PubMed ID: 19607765)
1. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure.
Newport DJ; Ritchie JC; Knight BT; Glover BA; Zach EB; Stowe ZN
J Clin Psychiatry; 2009 Sep; 70(9):1304-10. PubMed ID: 19607765
[TBL] [Abstract][Full Text] [Related]
2. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.
Ilett KF; Kristensen JH; Hackett LP; Paech M; Kohan R; Rampono J
Br J Clin Pharmacol; 2002 Jan; 53(1):17-22. PubMed ID: 11849190
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.
Stowe ZN; Hostetter AL; Owens MJ; Ritchie JC; Sternberg K; Cohen LS; Nemeroff CB
J Clin Psychiatry; 2003 Jan; 64(1):73-80. PubMed ID: 12590627
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine in breast milk and nursing infants: determination of exposure.
Newport DJ; Pennell PB; Calamaras MR; Ritchie JC; Newman M; Knight B; Viguera AC; Liporace J; Stowe ZN
Pediatrics; 2008 Jul; 122(1):e223-31. PubMed ID: 18591203
[TBL] [Abstract][Full Text] [Related]
5. Estimation of desvenlafaxine transfer into milk and infant exposure during its use in lactating women with postnatal depression.
Rampono J; Teoh S; Hackett LP; Kohan R; Ilett KF
Arch Womens Ment Health; 2011 Feb; 14(1):49-53. PubMed ID: 20960017
[TBL] [Abstract][Full Text] [Related]
6. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk.
Ilett KF; Hackett LP; Dusci LJ; Roberts MJ; Kristensen JH; Paech M; Groves A; Yapp P
Br J Clin Pharmacol; 1998 May; 45(5):459-62. PubMed ID: 9643618
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of venlafaxine extended release 75 mg and desvenlafaxine 50 mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.
Nichols AI; Focht K; Jiang Q; Preskorn SH; Kane CP
Clin Drug Investig; 2011; 31(3):155-67. PubMed ID: 21288052
[TBL] [Abstract][Full Text] [Related]
8. Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.
Jann MW; Spratlin V; Momary K; Zhang H; Turner D; Penzak SR; Wright A; VanDenBerg C
Eur J Clin Pharmacol; 2012 May; 68(5):715-21. PubMed ID: 22173281
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic medications in lactation.
Llewellyn A; Stowe ZN
J Clin Psychiatry; 1998; 59 Suppl 2():41-52. PubMed ID: 9559759
[TBL] [Abstract][Full Text] [Related]
10. Sertraline and desmethylsertraline in human breast milk and nursing infants.
Stowe ZN; Owens MJ; Landry JC; Kilts CD; Ely T; Llewellyn A; Nemeroff CB
Am J Psychiatry; 1997 Sep; 154(9):1255-60. PubMed ID: 9286185
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants in breast milk; comparative analysis of excretion ratios.
Schoretsanitis G; Augustin M; Saßmannshausen H; Franz C; Gründer G; Paulzen M
Arch Womens Ment Health; 2019 Jun; 22(3):383-390. PubMed ID: 30116895
[TBL] [Abstract][Full Text] [Related]
12. Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression.
Ilett KF; Watt F; Hackett LP; Kohan R; Teoh S
Ther Drug Monit; 2010 Dec; 32(6):704-7. PubMed ID: 20926994
[TBL] [Abstract][Full Text] [Related]
13. Venlafaxine and breast-feeding.
Hendrick V; Altshuler L; Wertheimer A; Dunn WA
Am J Psychiatry; 2001 Dec; 158(12):2089-90. PubMed ID: 11729040
[No Abstract] [Full Text] [Related]
14. Excretion of paroxetine into breast milk.
Ohman R; Hägg S; Carleborg L; Spigset O
J Clin Psychiatry; 1999 Aug; 60(8):519-23. PubMed ID: 10485633
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy.
ter Horst PG; Larmené-Beld KH; Bosman J; van der Veen EL; Wieringa A; Smit JP
J Clin Pharm Ther; 2014 Oct; 39(5):541-4. PubMed ID: 24989434
[TBL] [Abstract][Full Text] [Related]
16. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.
Berle JØ; Steen VM; Aamo TO; Breilid H; Zahlsen K; Spigset O
J Clin Psychiatry; 2004 Sep; 65(9):1228-34. PubMed ID: 15367050
[TBL] [Abstract][Full Text] [Related]
17. Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants.
Rampono J; Kristensen JH; Hackett LP; Paech M; Kohan R; Ilett KF
Br J Clin Pharmacol; 2000 Sep; 50(3):263-8. PubMed ID: 10971311
[TBL] [Abstract][Full Text] [Related]
18. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
Murrell MD; Cruz DA; Javors MA; Thompson PM
J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
[TBL] [Abstract][Full Text] [Related]
19. The effect of renal disease on the disposition of venlafaxine.
Troy SM; Schultz RW; Parker VD; Chiang ST; Blum RA
Clin Pharmacol Ther; 1994 Jul; 56(1):14-21. PubMed ID: 8033490
[TBL] [Abstract][Full Text] [Related]
20. Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS.
Wegler C; Saleh A; Lindqvist A; Nordeng H; Smeraglia J; Baranczewski P
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Aug; 1205():123340. PubMed ID: 35732105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
